Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Sales | 281 | 206 | 267 | 135 | 146 |
| Cost of Goods | 22 | 35 | 34 | 10 | 10 |
| Gross Profit | 258 | 172 | 233 | 126 | 136 |
| Operating Expenses | 606 | 515 | 618 | 643 | 930 |
| Operating Income | -348 | -344 | -384 | -517 | -794 |
| Other Income | 10 | -66 | 23 | -7 | -17 |
| Pre-tax Income | -338 | -410 | -361 | -524 | -811 |
| Net Income Continuous | -338 | -410 | -361 | -524 | -811 |
| Net Income | $-338 | $-410 | $-361 | $-524 | $-811 |
| EPS Basic Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-318 | $-314 | $-355 | $-488 | $-765 |